David J. Arthur is Chief Executive Officer of Salarius Pharmaceuticals, Inc.. Currently has a direct ownership of 48,019 shares of SLRX, which is worth approximately $67,226. The most recent transaction as insider was on Feb 13, 2023, when has been sold 14,300 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48K
0% 3M change
0% 12M change
Total Value Held $67,226

David J. Arthur Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2023
BUY
Grant, award, or other acquisition
-
14,300 Added 22.95%
48,019 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 37.23%
33,719 Common Stock
Nov 03 2022
BUY
Grant, award, or other acquisition
$17,300 $1.73 p/Share
10,000 Added 3.38%
285,674 Common Stock
May 26 2022
BUY
Open market or private purchase
$3,960 $0.18 p/Share
22,000 Added 7.24%
281,674 Common Stock
May 03 2022
BUY
Grant, award, or other acquisition
$1,900 $0.19 p/Share
10,000 Added 3.71%
259,674 Common Stock
Mar 03 2022
BUY
Open market or private purchase
$54,400 $0.39 p/Share
139,488 Added 35.84%
249,674 Common Stock
Nov 03 2021
BUY
Grant, award, or other acquisition
$5,716 $0.72 p/Share
7,939 Added 6.72%
110,186 Common Stock
May 03 2021
BUY
Grant, award, or other acquisition
$5,599 $0.57 p/Share
9,822 Added 9.26%
96,247 Common Stock
Nov 03 2020
BUY
Grant, award, or other acquisition
$2,732 $0.56 p/Share
4,879 Added 5.34%
86,425 Common Stock
DJA

David J. Arthur

Chief Executive Officer
Houston, TX

Track Institutional and Insider Activities on SLRX

Follow Salarius Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLRX shares.

Notify only if

Insider Trading

Get notified when an Salarius Pharmaceuticals, Inc. insider buys or sells SLRX shares.

Notify only if

News

Receive news related to Salarius Pharmaceuticals, Inc.

Track Activities on SLRX